We narrowed to 476 results for: gcamp6
-
Viral prep#100835-AAV2PurposeReady-to-use AAV2 particles produced from pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (#100835). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 plasmid DNA. CAG-driven, Cre-dependent GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGAvailable sinceJuly 8, 2020AvailabilityAcademic Institutions and Nonprofits only
-
pAAV.CAG.GCaMP6m.WPRE.SV40 (AAV1)
Viral prep#100840-AAV1PurposeReady-to-use AAV1 particles produced from pAAV.CAG.GCaMP6m.WPRE.SV40 (#100840). In addition to the viral particles, you will also receive purified pAAV.CAG.GCaMP6m.WPRE.SV40 plasmid DNA. CAG-driven GCaMP6m calcium sensor. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGAvailable sinceMarch 19, 2018AvailabilityAcademic Institutions and Nonprofits only -
pAAV-EF1a-4mtGCaMP6f-DIO (AAV1)
Viral prep#179529-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-EF1a-4mtGCaMP6f-DIO (#179529). In addition to the viral particles, you will also receive purified pAAV-EF1a-4mtGCaMP6f-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GCaMP8f. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable sinceFeb. 6, 2026AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSynapsin1-axon-GCaMP6m (AAV9)
Viral prep#111261-AAV9PurposeReady-to-use AAV9 particles produced from pAAV-hSynapsin1-axon-GCaMP6m (#111261). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-GCaMP6m plasmid DNA. Synapsin-driven expression of calcium sensor GCaMP6m in axons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynAvailable sinceSept. 27, 2023AvailabilityAcademic Institutions and Nonprofits only -
pAAV_BiCHATe27_GCaMP6f (AAV5)
Viral prep#213833-AAV5PurposeReady-to-use AAV5 particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceNov. 13, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV_BiVIPe4_GCaMP6f (AAV1)
Viral prep#213859-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
pCAG vGlut1 GCaMP5G
Plasmid#105008PurposePresynaptic calcium sensorDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertSLC17A7
ExpressionMammalianPromoterCAGAvailable sinceJan. 17, 2018AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pAAV_BiSSTe10_GCaMP6f (AAV1)
Viral prep#213818-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_BiSSTe10_GCaMP6f (#213818). In addition to the viral particles, you will also receive purified pAAV_BiSSTe10_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E10. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
pJMK019
Plasmid#42168DepositorInsertCaViar
UseLentiviralExpressionMammalianPromoterCMVAvailable sinceMay 22, 2013AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pAAV_BiPVe3_GCaMP6f (AAV PHP.eB)
Viral prep#213943-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiPVe3_GCaMP6f (#213943). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the PV+ basket cell-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
pOTTC810 - pAAV-EF1a-CRTsigpep-GCaMP3 (D324G+D360G+397G+D435G 10.19)-KDEL
Plasmid#63885PurposeAn AAV packaging vector that expresses ER-retained low-affinity GCaMP3 variant under control of the EF1a promoter.DepositorInsertER-localized low-affinity GCaMP3(10.19)
UseAAVPromoterEF1aAvailable sinceDec. 1, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pAAV_BiCHATe27_GCaMP6f (AAV1)
Viral prep#213833-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV_BiPVe4_GCaMP6f (AAV1)
Viral prep#213939-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV_BiSSTe4_GCaMP6f (AAV1)
Viral prep#213947-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
Cx36-GCaMP
Plasmid#123604PurposeMouse Connexin 36-GCaMP3 fusion for measuring gap junction localized calcium signaling - expresses in mammalian cellsDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertConnexin 36-GCaMP3 fusion (Gjd2 Mouse)
TagsGCaMP3ExpressionMammalianPromoterCMVAvailable sinceMarch 31, 2020AvailabilityAcademic Institutions and Nonprofits onlyCited by -
CARMEN
Plasmid#240464PurposeCompartment-specific measurements of Ca²⁺ dynamics by intensiometric Ca²⁺ biosensors targeted to mitochondria, cytosol and ERDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertCARMEN
ExpressionMammalianAvailable sinceOct. 3, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV_BiPVe4_GCaMP6f (AAV PHP.eB)
Viral prep#213939-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
pSADdeltaG-GCaMP3
Plasmid#32644DepositorPublicationHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertGCaMP3
UseRabies virusExpressionMammalianPromoterCMVAvailable sinceOct. 18, 2011AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pOTTC814 - pAAV-SYN1-CRTsigpep-GCaMP3 (D324G+D360G+397G+D435G 10.19)-KDEL
Plasmid#63887PurposeAn AAV packaging vector that expresses ER-retained low-affinity GCaMP3 variant under control of the SYN1 promoter.DepositorInsertER-localized low-affinity GCaMP3(10.19)
UseAAVPromoterhuman SYN1Available sinceDec. 1, 2015AvailabilityAcademic Institutions and Nonprofits only -
pAAV_BiVIPe4_GCaMP6f (AAV PHP.eB)
Viral prep#213859-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only